Syneron Bio
PrivateLast Round
Series B
Mar 31, 2026
Total Funding Raised
$250M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Syneron Bio operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a Series B round in March 2026.
Syneron Bio is a biotechnology company that has developed an AI-powered platform, Synova, for the discovery and development of macrocyclic peptide therapeutics targeting oncology, autoimmune, metabolic, and rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Syneron Bio Comparables
Compare Syneron Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Unnatural Products | 87% | |
| Vilya | 86% | |
| Orbis Medicines | 85% |
For institutional investors. Book with your work email.
Syneron Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 31, 2026 | ||||
| Series A | Dec 18, 2025 |
For institutional investors. Book with your work email.
Syneron Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KHK & Partners | Series A |
| BioTrack Capital | Series B |
| SV Health Investors | Series B |
| Hillhouse Investment | Series B, Series A |
| True Light Capital | Series B |
| 联想创投集团 (Lenovo Capital and Incubator Group) | Series B, Series A |
| CICC Capital | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 31, 2026
$150M round raised.
- Dec 18, 2025
$100M round raised.
For institutional investors. Book with your work email.
Syneron Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Syneron Bio's valuation, stock price, and market status.
Is Syneron Bio a public or private company?
Syneron Bio is a private company.
What is the current stock price of Syneron Bio?
Syneron Bio is a private company, so its shares have no public market price. Caplight tracks Syneron Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Syneron Bio worth (valuation)?
Valuation information for Syneron Bio is not publicly available.
Can I buy Syneron Bio stock?
Syneron Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Syneron Bio's last funding round?
Syneron Bio's most recent funding round was Series B on March 31, 2026.
Who are the main investors in Syneron Bio?
Key investors in Syneron Bio include CICC Capital, CDH VGC, Pfizer, CDH Investments, Decheng Capital.
Will Syneron Bio IPO soon?
No public IPO plans have been announced for Syneron Bio.
How can I track Syneron Bio secondary market activity?
Caplight tracks bids, offers, and trades in Syneron Bio's shares on secondary markets.